期刊文献+

C-反应蛋白在老年社区获得性肺炎与医院获得性肺炎中的比较研究 被引量:6

Comparison of C-reactive protein level between senile patients with community-acquired pneumonia and hospital-acquired pneumonia
原文传递
导出
摘要 目的分析血清C-反应蛋白(CRP)水平在老年不同病原菌肺部感染中的诊断作用。方法对医院的98例社区获得性肺炎(CAP)、128例医院获得性肺炎(HAP)住院患者血中CRP、白细胞(WBC)、中性粒细胞(N)进行测定,并对痰标本进行病原菌分离鉴定。结果 CAP、HAP患者血中CRP水平分别为(79.8±16.2)mg/L和(46.4±8.4)mg/L,两组间差异有统计学意义(P<0.01),而WBC、N则无明显差异;CAP患者病原菌检出率为43.88%,以革兰阳性球菌为主占27.55%,HAP患者病原菌检出率为63.28%,以革兰阴性杆菌为主占56.25%,两组患者的病原菌检出率、构成比差异均有统计学意义(P<0.01)。结论 CAP患者CRP水平显著高于HAP患者,两组患者感染的病原菌存在显著性差异,测定CRP水平有助于区分两组患者,指导临床合理选用抗菌药物。 OBJECTIVE To analyze the value of serum C-reactive protein(CRP) level in diagnosis of pulmonary in- fections in the senile patients. METHODS Totally 98 hospitalized patients with community-acquired pneumonia (CAP) and 128 patients with hospital-acquired pneumonia(HAP) were enrolled in the study, then the ratio of CRP, white blood count (WBC), and neutrophil (N) was determined, and the identification of pathogens isolated from the sputum specimens was performed. RESULTS The level of serum CRP was (79.8±16.2) mg/L in the CAP patients, (46.4±8.4)mg/L in the HAP patients, the difference between the two groups was significant (P 〈0.01), while the difference in the WBC or N was not significant. The detection rate of pathogens causing CAP was 43.88%, the gram-positive cocci accounted for 27.55% ; the detection rate of the pathogens causing HAP was 63.28%, the gram-negative bacilli accounted for 56.25% ; the difference in the detection rate of pathogens or the constituent ratio between the two groups was significant(P〈0.01). CONCLUSION The level of CRP in the CAP patients is significant higher than that in the HAP patients,and there is significant difference in the constituent ratio of pathogens between the two groups of patients' the determination of level of CRP can help distinguish the CAP patients from the HAP patients.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2013年第18期4384-4385,共2页 Chinese Journal of Nosocomiology
基金 总后卫生部保健局资助课题(B2000)
关键词 社区获得性肺炎 医院获得性肺炎 C-反应蛋白 Community-acquired pneumonia Hospital-acquired pneumonia C-reactive protein
  • 相关文献

参考文献2

二级参考文献15

  • 1李涛,吴正林,许香广,张国良,黄建平,胡雪松,李松,吴剑胜,方卫华.阿奇霉素对肺炎衣原体感染及冠心病二级预防的临床研究[J].中华医院感染学杂志,2004,14(7):730-733. 被引量:6
  • 2卢军,王军.老年患者呼吸机相关性肺炎的危险因素与防治对策[J].中华医院感染学杂志,2007,17(7):798-799. 被引量:34
  • 3Gurfinkel EP, Perez de la Hoz R, Brito VM, et al. Invasive vs non-invasive treatment in acute coronary syndromes and prior bypass surgery[J]. Int J Cardlol,2007,119(1) :65-72. 被引量:1
  • 4Dallas J,Kollef M. Severe hospital-acquired pneumonia: a review for clinicians[J].Curr Infect Dis Rep, 2009,11 (5) : 349- 356. 被引量:1
  • 5Vardakas KZ,Siempos II,Falagas ME. Diabetes mellitus as a risk factor for nosocomial pneumonia and associated mortality [J]. Diabet Med,2007,24,1168-1171. 被引量:1
  • 6Drakopoulou M,Toutouzas K,Stefanadi E,et al. Association of inflammatory markers with angiographic severity and extent of coronary artery disease[J]. Atheroselerosis,2009,206 (2):335-339. 被引量:1
  • 7Hong YJ, Jeong MH, Choi YH, et al. Plaque characteristics in culprit lesions and inflammatory status in diabetic acute coronary syndrome patients[J]. JACC Cardiovasc Imaging, 2009,2(3) : 339-349. 被引量:1
  • 8Ablij H,Meinders A. C - reactive protein: history and revival [ J ]. Eur J Intern Med, 2002,13(7) :412 -422. 被引量:1
  • 9Hmciarikovaa D, Juraskovaa B, Hysplera R, et al. A changed view of serum prealbumin in the elderly: prealbumin values influenced by concomitant inflammation [ J ]. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub, 2007, 151 (2) :273 - 276. 被引量:1
  • 10Gericke B, Raila J, Sehouli J, et al. Microheterogeneity of transthyretin in serum and ascitic fluid of ovarian cancer patients [ J ]. BMC Cancer, 2005, 17(5) : 133. 被引量:1

共引文献64

同被引文献45

  • 1社区获得性肺炎诊断和治疗指南[J].中华结核和呼吸杂志,2006,29(10):651-655. 被引量:3050
  • 2慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8233
  • 3Reissig A, Mempel C, Schumacher U, et al. Microbiological diagnosis and antibiotic therapy in patients with community- acquired pneumonia and acute COPD exacerbation in daily clinical practice : comparison to current guidelines[J] Lung,2013,191(3):239-246.DOI:10.1007/s00408-013-9460-x. 被引量:1
  • 4Stolz D, Christ-Crain M, Bingisser R, et al. Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy . Chest, 2007, 131 (1) :9-19. DOI: 10. 1378/chest. 06-1500. 被引量:1
  • 5Sehuetz P, Christ-Crain M, Thomann R, et al. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial [J] JAMA, 2009, 302 (10) : 1059-1066. DOI: 10. 1001/jama. 2009. 1297. 被引量:1
  • 6Foushee JA, Hope NH, Grace EE. Applying biomarkers to clinical practice:a guide for utilizing procalcitonin assays [J] .J Antimicrob Chemother, 2012, 67 (11): 2560-2569. DOI: 10. 1093/jac/dks265. 被引量:1
  • 7Juli6n-Jimnez A, Timbn Zapata J, Laserna Mendieta EJ, et al. Diagnostic and prognostic power of biomarkers to improve the management of community acquired pneumonia in the emergency department [J]. Enferm In{ecc Microhiol Clin, 2014,32(4) : 225-235. DOI: 10. 1016/j. eime. 2013.04. 015. 被引量:1
  • 8American Thoracic Society, Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare- associated pneumonia[J]. Am J Respir Crit Care Med, 2005, 171 (4) : 388-416. DOI : 10.1164/rccm. 200405-644ST. 被引量:1
  • 9陈利云,奚峰,周伟菊,汪瑞忠.成人社区获得性肺炎病原菌分布及其耐药性分析[J].世界临床药物,2009,30(3):172-176. 被引量:5
  • 10刘珊珊,刘雪白.C-反应蛋白在感染性疾病中的临床应用价值[J].新医学,2009,40(8):558-560. 被引量:13

引证文献6

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部